Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Cancers
|
November 27, 2021
Radiolabeled Bombesin Analogs
Rosalba Mansi, Berthold A Nock, Simone U Dalm, et al.
Nuclear Medicine and Biology
|
May 1, 2014
PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists
Mazen Jamous, Maria L Tamma, Eleni Gourni, et al.
Biopolymers
|
November 5, 2004
Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: synthesis and characterization
Rosalba Mansi, Diego Tesauro, Antonia De Capua, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 3, 2021
SPECT Imaging of SST2-Expressing Tumors with <sup>99m</sup>Tc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers
Raghuvir Haridas Gaonkar, Fabius Wiesmann, Luigi Del Pozzo, et al.
International Journal of Nanomedicine
|
May 24, 2014
Self-assembled or mixed peptide amphiphile micelles from Herpes simplex virus glycoproteins as potential immunomodulatory treatment
Antonella Accardo, Mariateresa Vitiello, Diego Tesauro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 16, 2013
Targeted radiotherapy of prostate cancer with a gastrin-releasing peptide receptor antagonist is effective as monotherapy and in combination with rapamycin
Rebecca A Dumont, MariaLuisa Tamma, Friederike Braun, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
January 13, 2010
Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours
Keelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2010
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Rosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 3, 2010
Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT
Damian Wild, Andreas Wicki, Rosalba Mansi, et al.
Journal of Medicinal Chemistry
|
June 16, 2023
Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications
Raghuvir Haridas Gaonkar, Yannik Tim Schmidt, Rosalba Mansi, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Cancers
|
November 27, 2021
Radiolabeled Bombesin Analogs
Rosalba Mansi, Berthold A Nock, Simone U Dalm, et al.
Nuclear Medicine and Biology
|
May 1, 2014
PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists
Mazen Jamous, Maria L Tamma, Eleni Gourni, et al.
Biopolymers
|
November 5, 2004
Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: synthesis and characterization
Rosalba Mansi, Diego Tesauro, Antonia De Capua, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 3, 2021
SPECT Imaging of SST2-Expressing Tumors with <sup>99m</sup>Tc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers
Raghuvir Haridas Gaonkar, Fabius Wiesmann, Luigi Del Pozzo, et al.
International Journal of Nanomedicine
|
May 24, 2014
Self-assembled or mixed peptide amphiphile micelles from Herpes simplex virus glycoproteins as potential immunomodulatory treatment
Antonella Accardo, Mariateresa Vitiello, Diego Tesauro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 16, 2013
Targeted radiotherapy of prostate cancer with a gastrin-releasing peptide receptor antagonist is effective as monotherapy and in combination with rapamycin
Rebecca A Dumont, MariaLuisa Tamma, Friederike Braun, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
January 13, 2010
Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours
Keelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2010
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Rosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 3, 2010
Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT
Damian Wild, Andreas Wicki, Rosalba Mansi, et al.
Journal of Medicinal Chemistry
|
June 16, 2023
Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications
Raghuvir Haridas Gaonkar, Yannik Tim Schmidt, Rosalba Mansi, et al.
Page
of 6